AIFF Rega marang bathi mangsa ngarep Firefly Neuro
Firefly Neuroscience, Inc (AIFF) is achieving a breakthrough in dementia and ADHD diagnostics through its BNA AI system. The optimization of cloud data in medicine is enhancing network profitability. The company's forward P/E valuation clearly demonstrates market balance, where the 0.00 mark serves as a current indicator. Business development relies on a team of EEG experts and data scientists creating innovative brain analysis methods.
Rincian analitis perusahaan Firefly Neuro (AIFF)
- kuotasi lan prakiraan analis:
- data kapitalisasi pasar:
- data ekuitas miturut neraca:
- indikator beban utang lan likuiditas:
Utang marang Ekuitas Firefly Neuroscience, Inc|AIFF - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Firefly Neuroscience, Inc|AIFF - Utang kumulatif perusahaan|Utang marang nilai buku Firefly Neuroscience Inc|AIFF - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Firefly Neuroscience|Rasio cepet fireflyneuro.com
- statistik bathi lan rasio pasar:
AIFF - Penghasilan resik perusahaan|Bathi mangsa ngarep Firefly Neuroscience, Inc|AIFF - Pangali P/E|Rega marang bathi mangsa ngarep Firefly Neuroscience Inc|AIFF - Koefisien bali modal nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Firefly Neuroscience Inc|AIFF - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Firefly Neuroscience|AIFF - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan fireflyneuro.com|AIFF - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Firefly Neuroscience, Inc
- data dodolan lan asil:
Analisis kabeh metrik perusahaan:Firefly Neuroscience AIFF
Institutional capital evaluates Firefly Neuroscience, Inc (AIFF) through the lens of future cash flows from the implementation of the BNA AI platform in clinics, where high switching costs for alternative software guarantee revenue stability. By analyzing the company's forward P/E ratio, the investor compares the current quote with expected net income, allowing for a distinction between fundamental revaluation and speculative optimism to determine the asset's actual reliability.
Pesaing langsung
Pangali Forward P/E BIIB|Kapitalisasi marang proyeksi bathi Neurocrine|Rega marang bathi mangsa ngarep Regencell RGC|Pangali mangsa ngarep rega marang bathi AXSM|ACADIA Pharmaceuticals - Pangali Forward P/E|Rasio prakiraan rega marang bathi xenon-pharma.com|VKTX: Pangali Forward P/E|Rasio rega marang bathi sing dikarepake SUPN (Supernus Pharmaceuticals, Inc.)|Rega marang bathi mangsa ngarep Catalyst Pharmaceuticals Inc|Rega marang bathi mangsa ngarep DNLI|Prakiraan rega marang bathi HRMY (Harmony Biosciences)|BHVN - Rasio prakiraan rega marang bathi|Amylyx Pharmaceuticals, Inc. - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi TRVI|PRAX - Rega marang bathi mangsa ngarep|AVXL (Anavex Life Sciences Corp) - Rasio rega marang bathi mangsa ngarep|CBLL: Pangali Forward P/E|Rasio prakiraan rega marang bathi Prothena (PRTA)|Prakiraan rega marang bathi ALEC|Pangali Forward P/E Annexon Biosciences|Rega marang bathi mangsa ngarep Omeros Corporation (OMER)|NGNE (Neurogene Therapeutics) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep AC Immune ACIU|voyagertherapeutics.com (VYGR) - Rasio prakiraan rega marang bathi|NMRA - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi Scilex Holding SCLX|TVGN: Pangali Forward P/E|Prakiraan rega marang bathi Alpha Cognition Inc.|CGTX (Cognition Therapeutics) - Pangali Forward P/E|inhibikase.com (IKT) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E SAVA|ASRT - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep Coya Therapeutics COYA|VTGN: Rasio rega marang bathi mangsa ngarep|Ovid Rx - Pangali Forward P/E|acumenpharm.com (ABOS) - Prakiraan rega marang bathi|CRVO: Pangali Forward P/E|Rasio prakiraan rega marang bathi Alterity Therapeutics Limited (ATHE)|Prakiraan rega marang bathi CLNN|PEPG: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E JUNS|Kapitalisasi marang proyeksi bathi relmada.com|Rega marang bathi mangsa ngarep Annovis Bio ANVS|GRCE: Rasio rega marang bathi mangsa ngarep|ANEW Medical, Inc. - Pangali Forward P/E|NeuroSense Therapeutics (NRSN) - Prakiraan rega marang bathi|RVPH: Pangali Forward P/E|MetaVia (MTVA) - Pangali Forward P/E|NRXS (NeurAxis) - Pangali Forward P/E|Helius Medical Technologies Inc. (HSDT) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E PASG|NEUP: Rasio rega marang bathi sing dikarepake|Pangali Forward P/E NERV (Minerva Neurosciences)|ATHA (athira.com) - Rasio rega marang bathi sing dikarepake|ADXN - Rega marang bathi mangsa ngarep|ALZN (Alzamend Neuro, Inc.) - Rasio rega marang bathi mangsa ngarep|CYCN: Pangali Forward P/E|Rasio prakiraan rega marang bathi Protagenic Therapeutics, Inc. (PTIX)|Prakiraan rega marang bathi KTTA|Pangali Forward P/E Cortigent Medical|Rega marang bathi mangsa ngarep Avenue Therapeutics, Inc. (ATXI)|BCLI (Brainstorm Cell Therapeutics Inc.) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Cara Therapeutics, Inc CARA|Chromocell (CHRO) - Rasio prakiraan rega marang bathi|Eliem - Pangali Forward P/E|Rasio rega marang bathi sing dikarepake ITCI|LBPH: Pangali Forward P/E|MRNS - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep NKGen|NRBO: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E SAGE|SNPX - Rasio prakiraan rega marang bathi|Pangali Forward P/E TRVN (Trevena)|VIGL (Vigil Neuroscience Inc.) - Rasio rega marang bathi sing dikarepake|WENA - Rega marang bathi mangsa ngarep|CERE: Rega marang bathi mangsa ngarep
